Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Pinteon Therapeutics

Pinteon Therapeutics
2014 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$10M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of cancer therapeutics drugs intended to cure cis-trans isomerase. The company's drugs are based out of biotechnological compounds focused on the discovery and development of therapeutics targeting Pin1 and related targets, enabling researchers to normalize aberrant disease processes and improve patient outcomes in these high unmet medical need indications.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1188 Centre Street
  • Newton Centre
  • Newton, MA 02459
  • United States

+1 (917) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pinteon Therapeutics’s full profile, request a free trial.

Pinteon Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) 17-Aug-2017 $10M 0000 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Pinteon Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Pinteon Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Morningside Group PE/Buyout Minority 000 0000 000000 0